Feb 23, 2009 (Datamonitor via COMTEX) –
— Medtronic, a medical technology company, has received approval from the FDA for a humanitarian device exemption for its Reclaim deep brain stimulation therapy for chronic, severe obsessive-compulsive disorder.
The company also announced the first enrollment in its multi-center, randomized clinical trial of deep brain stimulation (DBS) for treatment-resistant depression.
Medtronic is proceeding with Read the rest of this entry »

MADISON, Wis.
– Patients cannot sue the makers of potentially unsafe medical devices approved for sale by federal regulators, the Wisconsin Supreme Court ruled Tuesday.
The court ruled against a Wisconsin man who had surgery to remove a defibrillator after the manufacturer, Medtronic, Inc., warned its battery had a chance of failing. The ruling is a victory for Minneapolis-based Medtronic and other manufacturers who want to limit product liability.
Read the rest of this entry »

(RTTNews) - 
Medtronic Inc. (MDT:
) announced that it has appointed Francine Kaufman as vice president of Global Medical Affairs, for the Diabetes business.
Kaufman is a Professor of Pediatrics and Communications at the Keck School of Medicine and the Annenberg School of Communications of USC, and Head of the Center for Diabetes, Endocrinology and Metabolism at CHLA.
Kaufman has served as a delegate to the World Read the rest of this entry »

Citing a recent U.S. Supreme Court decision, a federal judge in St. Paul on Monday dismissed dozens of lawsuits filed by patients who claimed they were injured by a heart device made by Medtronic Inc.
The patients were implanted with an electrical lead used in a defibrillator system known as Sprint Fidelis made by the Fridley-based medical technology company.
In October 2007, Medtronic’s popular Sprint Fidelis lead was recalled by the Food and Read the rest of this entry »

comments in the third and fourth
paragraphs.)
-(Dow Jones)- The Food and Drug Administration Thursday approved
the first implantable device designed to deliver electrical therapy to the brain
to suppress symptoms associated with severe obsessive-compulsive disorder.
The device, known as Reclaim DBS (deep brain stimulation) Therapy, is made by
Medtronic Inc.
(MDT). The product was approved to treat patients with OCD in
cases where drug and Read the rest of this entry »

A potent substance used in spine-repair surgery to promote bone growth has been linked to life-threatening complications in dozens of patients.
Many of the complications involving the product, Medtronic Inc.’s Infuse Bone Graft, have occurred during “off label” uses, when surgeons use it in ways that haven’t been approved by the Food and Drug Administration.
The FDA warned surgeons in July that it had received reports of life-threatening complications Read the rest of this entry »

*Results may vary, certain patients may benefit -FDA
(Adds product details, background, byline)
WASHINGTON, Feb 19 (Reuters) – U.S. health officials have
approved Medtronic Inc’s (
MDT.N
) implantable deep brain
stimulator to help treat patients with severe
obsessive-compulsive disorder.
The Reclaim DBS Therapy device, was cleared on Thursday
under the U.S. Food and Drug Administration’s human device
exemption policy.
Human device exemptions Read the rest of this entry »

*Results may vary, certain patients may benefit -FDA
(Adds product details, background, byline)
WASHINGTON, Feb 19 (Reuters) – U.S. health officials have
approved Medtronic Inc’s (
MDT.N
) implantable deep brain
stimulator to help treat patients with severe
obsessive-compulsive disorder.
The Reclaim DBS Therapy device, was cleared on Thursday
under the U.S. Food and Drug Administration’s human device
exemption policy.
Human device exemptions Read the rest of this entry »

(RTTNews) - 
Friday, Physio-Control, Inc., a unit of medical technology company,Medtronic, Inc. (MDT:
), said it received clearance by the FDA to market the LIFEPAK 20e defibrillator/monitor in the U.S. The 20e was developed to be easily transportable and facilitate hospitals in having resuscitation services readily available in all facility areas.
The 20e is an improvisation of the LIFEPAK 20 defibrillator/monitor, Read the rest of this entry »

Patients suffering from severe obsessive-compulsive disorder that has not responded to medication and psychotherapy appropriately have now the chance to improve their condition thanks to a new device approved by the Food and Drug Administration on Thursday.
The device, called Reclaim Deep Brain Stimulator, is made by Medtronic, the leading player in the so-called neuromodulation market. Although patients receiving the device will continue to have Read the rest of this entry »